The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II clinical trial of autologous CMV-specific cytotoxic T cells (CMV-TC) for glioblastoma: Dose escalation results.
 
Marta Penas-Prado
Consulting or Advisory Role - AGIOS; Lilly
Research Funding - Abbvie (Inst); Agios (Inst); AROG (Inst); DelMar Pharmaceuticals (Inst); DNAtrix (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Novartis (Inst); Orbus Therapeutics (Inst)
 
Katayoun Rezvani
No Relationships to Disclose
 
Shiao-Pei S. Weathers
No Relationships to Disclose
 
Shouhao Zhou
No Relationships to Disclose
 
Carlos Kamiya-Matsuoka
No Relationships to Disclose
 
Barbara Jane O'Brien
Honoraria - Monteris Medical
Consulting or Advisory Role - Abbvie
Travel, Accommodations, Expenses - Kadmon
 
Monica Elena Loghin
No Relationships to Disclose
 
Rebecca Anne Harrison
No Relationships to Disclose
 
Be Lian Pei
No Relationships to Disclose
 
Sandra Ictech
No Relationships to Disclose
 
Kathy Hunter
No Relationships to Disclose
 
W. K. Alfred Yung
Honoraria - Amgen; DNAtrix
Consulting or Advisory Role - Amgen; DNAtrix
 
John Frederick De Groot
Employment - Helsinn Therapeutics (I); ZIOPHARM Oncology (I)
Leadership - ZIOPHARM Oncology (I)
Stock and Other Ownership Interests - Gilead Sciences; ZIOPHARM Oncology (I)
Consulting or Advisory Role - Abbvie; AstraZeneca; Boston Biomedical; CarThera; Celldex; Deciphera; Five Prime Therapeutics; Foundation Medicine; Genentech/Roche; GW Pharmaceuticals; Insys Therapeutics; Kadmon; Merck; Novogen; Omniox; Oxigene; Vascular Biogenics
Research Funding - Deciphera; EMD Serono; Lilly; Mundipharma; Novartis; Sanofi
Patents, Royalties, Other Intellectual Property - AstraZeneca - Research Support; Deciphera Pharmaceuticals - Research Support; Eli Lilly - Research Support; EMD-Serono - Research Support; Novartis - Research Support; Sanofi-Aventis - Research Support
 
Elizabeth J. Shpall
No Relationships to Disclose
 
Amy B. Heimberger
Stock and Other Ownership Interests - Caris Life Sciences; Celldex
Consulting or Advisory Role - Caris Life Sciences
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - Celldex
Travel, Accommodations, Expenses - Caris Life Sciences